Abstract
Macrophages are the main intrinsic immune cells in the cochlea; they can be activated and play a complicated role after cochlear injury. Many studies have shown that the number of macrophages and their morphological characteristics within the major cochlear partitions undergo significant changes under various pathological conditions including acoustic trauma, ototoxic drug treatment, age-related cochlear degeneration, selective hair cell (HC) and spiral ganglion neuron (SGN) elimination, and surgery. However, the exact role of these macrophages after cochlear injury is still unclear. Regulating the migration and activity of macrophages may be a therapeutic approach to reduce the risk or magnitude of trauma-induced hearing loss, and this review highlights the role of macrophages on the peripheral auditory structures of the cochlea and elucidate the mechanisms of macrophage injury and the strategies to reduce the injury by regulating macrophage.
Introduction
Macrophages are cellular components of the innate immune system and have the hallmarks of heterogeneity and plasticity, and they play important roles in homeostasis, repair, and pathological changes. They are mainly transformed by monocytes from circulation and reside in virtually all tissues. In general, there are three main sources of macrophages in adult tissues in the absence of external stimuli, namely, fetal liver monocytes, yolk sac macrophages, and bone marrow (BM)-derived monocytes (). Macrophages can sense the microenvironment and differentiate into two distinct phenotypes, which consist of M1 and M2 subsets. M1 are called classically activated or inflammatory macrophages and M2 are called alternatively activated or wound-healing macrophages ().
Macrophages are the main executive cells of the immune system in the cochlea. They reside in multiple anatomic sites including the basilar membrane, osseous spiral lamina (OSL), spiral ganglion, spiral ligament, and stria vascularis (; ; ; ; Figure 1). Although the exact function of these macrophages is unclear, their widespread distribution in the cochlea implies that they participate in maintaining cochlear homeostasis and preventing diseases. Indeed, many studies have shown that immune system contribute to the development of noise-related hearing loss, drug-related hearing loss, and age-related hearing loss (Yang et al., 2015; ; ). Cochlear implant surgery, currently the only effective method for treating severe sensorineural hearing loss (SNHL), can also trigger an immune response (). As the main specialized immune cells in the cochlea, the number of macrophages and their morphological characteristics at various cochlear locations undergo significant changes, and the local environmental factors that facilitate macrophage differentiation and behavior are also significantly altered after cochlear damage, which supports the idea that macrophages play a key role in response to cochlear injury ().
FIGURE 1
Macrophages migrate into the cochlea in response to damage caused by noise exposure, ototoxicity, surgery, or age-related degeneration. Damage-associated molecular patterns (DAMPs) produced by injured tissue bind to pattern recognition receptors (PRRs) expressed on the macrophages, and this activates resident macrophages to secrete pro-inflammatory cytokines, leading to apoptosis of injured cells and promoting further infiltration of immune cells (). However, some studies suggest that the recruitment of macrophages can promote the survival of spiral ganglion neurons (SGNs) and the spontaneous recovery of ribbon synapses after cochlear injury (, , ). Moreover, some studies demonstrate that macrophages can engulf dead cells and cellular debris in the organ of Corti and promote the regeneration of hair cells (HCs) in damaged sensory epithelium (). These results suggest that macrophages not only play a damaging role, but also play a protective role after cochlear injury (Table 1).
TABLE 1
| Macrophage function | |||||
| Injury Model | HC | Spiral ligament | Stria vascularis | Ribbon synapse | SGN |
| Noise exposure | HC degeneration and phagocytosis | Pro-inflammatory role | Maintain integrity of BLB | Promote recovery | Promote survival |
| Ototoxic drug treatment | HC degeneration, phagocytosis, and regeneration | Pro-inflammatory role | Promote survival | ||
| Aging | HC degeneration and phagocytosis | Maintain integrity of BLB | |||
| Selective HC elimination | HC phagocytosis | Promote survival | |||
| Selective SGN elimination | Repair | ||||
| Cochlear implantation | Anti-inflammatory role | Pro-inflammatory role | Anti-inflammatory | ||
The role of macrophages on the hair cell (HC), spiral ligament, stria vascularis, ribbon synapse, and spiral ganglion neuron (SGN) in different injury models.
To understand the precise role of cochlear macrophages after aseptic injury, we firstly review the origin, the distribution, and the influence of macrophages on the peripheral auditory structures of the cochlea. We then describe the changes of cochlear macrophages after aseptic injury, the signaling pathways leading to the activation of macrophages, and the secretion of inflammatory cytokines in response to damage. Finally, we present the currently available methods for inhibiting macrophage-induced damage.
The Origin of Cochlear Macrophages
Although the inner ear was once considered as an immune privileged organ, recent studies have shown that macrophages are present in the inner ear and play critical roles in the immune response of the inner ear. Resident macrophages of the cochlea may have different origins according to the stages of development. In the early development of the mouse cochlea, macrophages arise via hematopoiesis in the yolk sac. Macrophages first appear at about embryonic day (E) 10.5 in the developing otocyst and then gradually migrate into the mesenchyme of the cochlea during the embryonic stage and subsequently take up residence especially in the postnatal cochlear spiral ligament, the stria vascularis, and the spiral ganglion. The density of mouse cochlear macrophages increases with growth, reaches a peak around the neonatal stages, and decreases from postnatal day 3 (P3). In addition, macrophages in the cochlea have the ability to proliferate in situ, especially during the perinatal period (). In the adult mouse cochlea, tissue-resident macrophages are gradually replaced by BM-derived cells over the course of several months in the steady state (; ; ). Therefore, the number of macrophages can change rapidly after cochlear injury to protect against or aggravate cochlear tissue injury.
Distribution of Tissue Macrophages in Mature Cochlear Tissues
Macrophages in the Basilar Membrane
The basilar membrane contains two sets of macrophages—one on the organ of Corti side and the other on the scala tympani side—and these two sets show different developmental patterns and fates after birth. At birth, macrophages on the organ of Corti side are morphologically completely differentiated. However, they have a very short life span and undergo developmental deterioration as the sensory epithelium matures (). Thus, immune cells in the organ of Corti are absent under homeostatic conditions (; ; ; Yang et al., 2015). Macrophages on the scala tympani side are round shape at P1 and begin site-specific differentiation at P4. Macrophages in the apical turn show dendritic morphology, while macrophages of the middle and basal turns have irregular morphologies with short projections, and macrophages of the basal turn can further differentiate and transform into an amoeboid morphology ().
The entire length of the basilar membrane contains macrophages, and this is the case in a variety of species such as mice, chickens, zebrafish, and humans (; Warchol et al., 2012; ). These macrophages are the closest immune cells to sensory cells in terms of physical distance and can sense pathological changes in sensory cells. There are two different extracellular environments surrounding these macrophage populations, with one surface contacting the basement membrane and mesothelial cells and the other surface contacting the perilymph, and these different environments allow the cells to monitor the immune environments within the organ of Corti and perilymph. Moreover, macrophages are less restricted physically due to the acellular environment of scala tympani, and thus they change their morphology and migrate more easily ().
Macrophages in the Lateral Wall
There are two types of macrophages in the lateral wall of the cochlea, namely, macrophages in the spiral ligament and perivascular macrophage-like melanocytes (PVM/Ms) in the stria vascularis (Zhang et al., 2012). Macrophages in the spiral ligament are irregularly shaped with branches and processes and they are distributed abundantly on the inferior site of spiral ligament (Wang et al., 2002; ). The inferior site is adjacent to the scala tympani, which is where leukocytes mainly accumulate after acute injury (; ). Morphological analysis has also demonstrated that the surface of the inferior site contains micropores (), and these microcellular structures allow the perilymph to enter the spiral ligament, thereby enabling communication between the perilymph and the macrophages of the spiral ligament.
The cochlea has a blood–labyrinth barrier (BLB), which maintains the microenvironment of the cochlea and separates the blood vessels of the stria vascularis from systemic circulation. The BLB is constituted by endothelial cells, a large number of PVM/Ms with both macrophage and melanocyte characteristics, pericytes, and the underlying basement membrane (Zhang et al., 2012). The PVM/Ms are in close contact with blood vessels through cytoplasmic processes, and they wrap around endothelial cells and pericytes to form structures that are essential for maintaining normal capillary architecture ().
Macrophages in the Neural Tissues
Macrophages are present around the neural tissue of the cochlea, which is composed of SGN and their peripheral nerve fibers inside both the OSL and the modiolus. Macrophages distributed in the OSL region are roughly arranged into two rows—one near the SGNs and the other near the edge of the OSL. Although most of these macrophages lie in a direction parallel to the radial fibers of the tunnel, some macrophages are vertically oriented. These cells can extend their processes to the region of inner HCs through the habenula perforata without contact with inner HCs. Although the function of these macrophage processes is not fully understood, their adjacency to cochlear ribbon synapses suggests a role in removing degraded sensory cells in the organ of Corti after injury and maintaining synapse homeostasis, a function that has been identified in microglia, which are the resident macrophages in the central nervous system (CNS) (Wake et al., 2009; ).
Chemokine Signaling Recruits Macrophages Into Cochlear Tissue
Cochlear injury results in the rapid accumulation of macrophages, but identifying the signaling pathways mediating this recruitment has proven to be challenging. The main reason for this is that cochlear damage includes not only HCs, but also other types of cells in the cochlea such as supporting cells, lateral wall fibrocytes, and SGNs, and these cells might generate their own signaling molecules for recruiting macrophages. So far, two chemokine signaling pathways that recruit macrophages have been studied in the cochlea.
Mononuclear phagocytes consist of monocytes, dendritic cells, microglia, and tissue macrophages, and these cells can be divided into two distinct populations (). One population is the CX3CR1-expressing mononuclear phagocytes, the majority of which are tissue macrophages such as those in the cochlea and microglia in the CNS (). The only ligand for CX3CR1 is CX3CL1, also known as fractalkine. Neurons and endothelial cells, including SGNs and HCs, express high levels of CX3CL1 (), which can stimulate and signal macrophages through the CX3CR1 receptor after cochlear injury, thus regulating the adhesion and migration of macrophages (). The other population is the CCR2-expressing monocytes. CCR2 binds to its ligand CCL2 and plays a unique role in recruiting mononuclear cells (). Although CCR2-expressing monocytes do not remain as resident cells in peripheral organs for long periods, they can transdifferentiate and act as a precursor for resident macrophage (). In addition, CCR2 plays a crucial role in the release of monocytes into the circulation from the BM (). Once in circulation, CCR2-expressing monocytes can migrate from the blood circulation to peripheral tissues, even though cells of the inner ear do not express CCL2 or CCR2 (; ).
Important distinctions have been found between CX3CR1 and CCR2 macrophages not only in terms of their surface markers, but also in terms of their effector function in immune responses (). CX3CR1-expressing cells become numerous in the inner ear after excessive noise exposure and in response to aminoglycoside ototoxicity, while CCR2-expressing cells enter the cochlea after lipopolysaccharide exposure and other forms of cochlear damage, such as bacterial meningitis ().
The Role of Macrophages in Different Structures of the Cochlea
Macrophages Play a Complicated Role in the Basilar Membrane
Sensory Cell Degeneration
Macrophages are immune sensors that detect changes in the microenvironment of the organ of Corti, and mature tissue macrophages can influence the pathogenesis of the sensory cell and the degeneration of sensory cells in the early stage (Yang et al., 2015; ; Zhang et al., 2017). Sensory cells are completely degraded by 10 weeks after amikacin treatment, while the macrophage density increases significantly over the same time period (). Macrophages trigger inflammation by releasing inflammatory cytokines in response to cochlear sensory epithelium injury (), and cochleae with greater numbers of outer HC lesions have significantly more mature tissue macrophages than cochleae with less outer HC lesions (Yang et al., 2015; ). Together, these observations suggest that macrophages are involved in epithelial degeneration.
Phagocytosis of HC Debris
Macrophages play a role in removing waste products from the organ of Corti (Wang and Li, 2000). Because there are no resident macrophages in the organ of Corti under physiological conditions, macrophages outside of the organ of Corti can stretch out their processes into the region of inner HCs in order to eliminate cellular debris (). In addition, macrophages can migrate into the organ of Corti in severely injured cochlea in which the overall structure of the organ of Corti is destroyed (), and macrophages have been observed engulfing degenerated cells and debris in the tunnel of Corti and outer HC region 5 days after acoustic injury ().
HC Regeneration
Several studies have demonstrated that macrophages release signals that influence the early stages of HC regeneration in the damaged sensory epithelium. It has been shown that an increase in the number of macrophages precedes the proliferation of HC precursors in the damaged sensory epithelium of the avian inner ear after treatment with aminoglycosides (). In addition, the latency with which macrophages are recruited into injured regions is about 4–8 h, which implies a role of macrophages in the initiation of HC regeneration (Warchol, 1997). Finally, the regeneration of HCs is significantly delayed by the genetic ablation of macrophages that would normally be recruited to the region of injury or local ablation of these macrophages using clodronate liposomes ().
Two Types of Macrophages Play Different Roles in the Lateral Wall
Macrophages of the Spiral Ligament Are Responsible for Inflammatory Responses
Bone marrow-derived resident macrophages exist in the spiral ligament and can be activated by various kinds of damage, such as noise exposure, ototoxic drug application, and surgical stress. These macrophages communicate with spiral ligament fibrocytes and are responsible for the inflammatory response (), which is detrimental to hearing recovery ().
PVM/Ms in the Stria Vascularis Maintain the Integrity of the BLB
Macrophages play an role not only in immunity but also in mediating the integrity and permeability of the BLB in the stria vascularis (Zhang et al., 2012; ). Infiltrating macrophages migrate to BLB to update PVM/Ms, and noise exposure can accelerate the circulation of PVM/Ms (; ). The absence of PVM/Ms results in an increase in BLB permeability to both low and high molecular weight tracers (Zhang et al., 2012). PVM/Ms are also critical for establishing and maintaining the endocochlear potential (Zhang et al., 2013), and PVM/M-depleted animals show a substantial drop in endocochlear potential accompanied by hearing loss (Zhang et al., 2012). In addition, stria vascularis degeneration defined as hyperpigmentation is related to macrophage invasion (). Taken together, these observations suggest that PVM/Ms alter the BLB not only through immune responses, but also via physical and molecular dysfunctions that are different from macrophages in other regions of the cochlea.
Macrophages Promote Ribbon Synapse Development and Recovery After Injury
Recent studies have suggested that macrophages may promote the development of ribbon synapses in the cochlea. Ribbon synapses are the locations where glutamate is released from HCs onto the peripheral afferent terminals of SGNs in response to sound input. In the CNS, microglia cells take part in the formation and remodeling of synapses, and they can remove weakly active synapses and do so in response to factors such as CX3CL1 (; Wu et al., 2015). Some studies have shown that macrophages in the cochlear OSL might have similar effects to the microglia in the CNS. Macrophages in the OSL are present in early development after birth and near the ribbon synapses (), which suggests a role for these cells in ribbon synapse formation. Meanwhile, the number of macrophages is highest between P1 and P10 (), corresponding to the initial period of ribbon synapse formation and pruning (; ). Importantly, macrophages appear to enhance functional ribbon synapse recovery after noise injury ().
Macrophages Protect Auditory Nerve After Injury
Recent studies have identified the important role of macrophages in SGN protection (, , ). BM-derived macrophages are involved in the repair of the auditory nerve after injury to SGN and are important resources for promoting auditory nerve remodeling in the adult cochlea (). Cochlear macrophages remove redundant glial cells during the development of the auditory nerve, and depletion of macrophages leads to an increase in the number of glial cells, abnormal formation of myelin sheaths, and impaired hearing functions (). Macrophages also help to clear SGNs undergoing apoptosis during early postnatal stages, which is the time of ribbon synapse development (). Moreover, macrophages have been demonstrated to prevent loss of SGNs when the cochlea is injured (, ).
Changes and Effect of Macrophages on Cochlear Structure Caused by Cochlear Injury
Macrophages in Noise-Induced Hearing Loss
Acoustic trauma can activate the immune defense function of the cochlea (Yang et al., 2016). At present, two noise exposure levels have been used to investigate macrophages in the cochlea. Lower level noise (LLN) is that which causes only temporary threshold shifts without HC loss, while higher level noise (HLN) is that which causes permanent threshold shifts accompanied by HC loss. Both LLN and HLN can rapidly increase the number of macrophages and lead to alterations in macrophage shape in the basilar membrane, OSL, and spiral ganglion (; ). Studies have shown that the phagocytic ability of macrophages is reduced and that the activated macrophage morphology does not fully recover until 2 months after LLN exposure (). In addition, the expression of the major histocompatibility complex class II (MHC II) antigen-presenting protein by basal monocytes and macrophages increases after HLN. CD4+ T cells also infiltrate into the same region after noise exposure, suggesting that the activation of the antigen presentation function is site-dependent, and these cells connect innate immunity to the adaptive immune response (Yang et al., 2015).
CX3CR1 and CCR2 knockout have no significant effect on the number of macrophages in the sensory epithelium or spiral ganglion after acoustic injury (; ; ), nor does the absence of CX3CR1 in mice have any striking effect on HCs or spiral ligament injuries or on hearing thresholds after HLN exposure (). However, noise-induced HC death is significantly increased in the CCR2 knockout mice. This observation suggests that CCR2 may have a protective effect in the cochlea after acoustic injury ().
Noise exposure causes activation of PVM/Ms and destroys the BLB (; Yang et al., 2011; Zhang et al., 2013). Bone marrow-derived cells (BMDCs) migrate to the BLB areas of the damaged cochlea in the first week after noise exposure and further accumulate in the second week. After 4 weeks, the BMDCs become fused with blood vessels (). Activated PVM/Ms show reduced contact with capillaries and a great distance from pericytes and endothelial cells (Zhang et al., 2013; ), and they produce less pigment epithelium growth factor, which is crucial for stabilizing the BLB and for maintaining normal hearing functions (; Zhang et al., 2012).
Although the mechanism is still unclear, macrophages and CX3CR1 signaling are suggested to contribute to ribbon synapse recovery in response to damage. LLN leads to rapid ribbon synapse degeneration, with macrophages immediately migrating into the injured synaptic region. The injured synapses can spontaneously recover in animals with intact CX3CR1 signaling. However, a lack of CX3CR1 signaling reduces synaptic recovery and increases neuronal loss after noise exposure (; Figure 2).
FIGURE 2
Macrophages in Ototoxic Drug-Induced Hearing Loss
Recent studies have focused mainly on the effect of ototoxic drugs on the number of macrophages and on how CX3CR1 expressed on macrophages regulates the effects of ototoxic drugs on cochlear injury. Kanamycin/furosemide treatment increases the numbers of macrophages in the sensory epithelium, spiral ganglion, and spiral ligament (; ). CX3CR1 deficiency results in a decrease in macrophages in the sensory epithelium and has no impact on the recruitment of macrophage into the spiral ganglion, but leads to increased SGN loss (). This implies that CX3CR1 may have distinct roles on the cochlear epithelium or the spiral ganglion after kanamycin/furosemide exposure.
Neomycin increases the expression of CX3CL1 on HCs and the expression of CX3CR1 on macrophages in the basilar membrane, and CX3CL1 activates macrophages and increases cytokine levels in the cochlea. A lack of CX3CR1 results in the survival of significantly greater numbers of cochlear HCs after neomycin treatment in vitro, which suggests that CX3CL1/CX3CR1-mediated macrophage activation has a damaging effect on HCs (). However, another study showed that the absence of CX3CR1 on macrophages leads to more severe hearing loss and exacerbates HC loss after kanamycin exposure. In addition, macrophages are more concentrated in the high-frequency region of the cochlea and are more abundant in the spiral ligament after CX3CR1 knockout (). These discrepancies suggest that further exploration of the effect of CX3CR1 on HCs in the cochlea is needed.
Macrophages in Age-Related Hearing Loss
The development of presbycusis is affected by immune function (), and age-related immune system dysfunction can accelerate presbycusis (). At present, the research in this area is mainly focused on changes in basilar membrane macrophages and PVM/Ms in the aging cochlea.
There is no mass inflammatory cell infiltration in the basilar membrane of the aging cochlea, and in fact, the macrophage numbers decrease with age (). The main immune cell reaction is inflammatory activation of resident mature macrophages characterized by morphological changes, including increased size and transformation into an amoeboid form (; Zhang et al., 2017). Macrophage activation precedes the onset of sensory cell pathogenesis, and there is a morphological transition from branching to more round or amoeboid morphology in the areas that are undergoing active sensory cells pathogenesis. However, when the degeneration of sensory cells is completed, the number of macrophages decreases and the morphology of the macrophages returns to a resting state in that area.
In the stria vascularis of the aging cochlea, PVM/Ms show a significant decrease in density and size, but a significantly greater amount of melanin. Most of the PVM/Ms are branched and are arranged in a self-avoidance pattern in the younger cochlea, while the PVM/Ms are flattened and amoeboid and show less physical contact with the capillaries in some regions of the older cochlea ().
Macrophages in the Cochlea After Selective HC or SGN Elimination
Damage to HCs or SGNs alone is sufficient to recruit macrophages into the cochlea. Pou4f3 is a HC-specific transcription factor, and the application of diphtheria toxin (DT) results in almost complete removal of cochlear HCs in mice selectively expressing human DT receptor under Pou4f3 control, with no significant pathological changes in the supporting cells, SGNs, or cochlear lateral wall cells (). The death of HCs leads to an increase in basilar membrane and spiral ganglion macrophages (; Figure 3). The number of basilar membrane macrophages peaks at 14 days after HC loss and then begins to decrease, while the number of spiral ganglion macrophages remains elevated for at least 56 days. When CX3CR1 signaling is disrupted, the number of recruited macrophages in the sensory epithelium and spiral ganglion is reduced and cochlear SGN loss increases (; Figure 4).
FIGURE 3
FIGURE 4
Ouabain inhibits Na/K-ATPase activity, and applying ouabain to gerbils and mice via the round window can rapidly and highly selectively eliminate type I SGNs without leading to cellular degeneration in the organ of Corti or the cochlear lateral wall (; , ). The number of macrophages in the spiral ganglion increases 3 days after ouabain exposure (). The expression of genes that are linked to macrophage activation is upregulated, and the infiltrating macrophages show an amoeboid or large round shape, indicating that the macrophages have reactive or engulfment functions.
Macrophages in the Cochlea Following Cochlear Implantation
The phagocytic and anti-inflammatory activities of macrophages are both enhanced after cochlear implantation (; ). In a study of patients with unilateral cochlear implantation, activated and phagocytosing macrophages were found in both the fibrotic sheath around the electrode track and the fibrous tissue with infiltrating lymphocytes in the implanted ears, and macrophage densities in the OSL and Rosenthal’s canal in the implanted ears were markedly higher than in the unimplanted ears (). The insertion of an electrode array into the mouse cochlea induces increased macrophage infiltration with M1 macrophages playing a main role in the spiral ligament and M2 macrophages playing a main role in the organ of Corti and spiral ganglion, and both M1 and M2 macrophages are present at the wound site around the inserted electrode ().
Macrophage Activation Signaling in Response to Tissue Injury
Macrophages have a protective effect on synapses and SGNs, but the mechanisms are still unknown. Numerous studies have shown that activated macrophages produce inflammatory mediators that are involved in cochlear injury. At present, most studies on cochlear macrophages are performed in aseptic injury models, which suggest that any observed cochlear inflammation must be an endogenous response to cellular stress or injury. Sterile inflammation of other organ systems is closely related to the DAMPs that are released by stressed or damaged tissues (Tang et al., 2012; ) and that can recognize and activate the PRRs on the surfaces of macrophages. PRR activation can rapidly activate resident macrophages that secrete pro-inflammatory cytokines and produce reactive oxygen species, leading to apoptosis of damaged cells and the infiltration of immune cells (; ; Tsung et al., 2007).
Toll-like receptor 4 (TLR4) is one of many PRRs that can be activated in aseptic inflammation, and TLR4 activation can promote the production of reactive oxygen species and the activation of canonical NF-kB (; ). Several studies have shown that TLR4 activation is one of the pathways that leads to cochlear inflammation after noise exposure or ototoxic drug treatment. Macrophages of the basilar membrane in the cochlea constitutively express TLR4 (Figure 5), but the lack of TLR4 has no impact on hearing functions under normal conditions (Vethanayagam et al., 2016). Although the exact ligand that activates TLR4 after noise exposure or ototoxic drug treatment is unknown, each type of injury leads to significantly increased expression of TLR4 in the cochlea within hours of the injury (; ; Vethanayagam et al., 2016). TLR4 activation caused by noise damage or cisplatin treatment results in NF-kB activation and promotes the production of TNF-α, IL-1β, and IL-6 (; ; Zhang et al., 2019). Cisplatin treatment in TLR4-deficient mice results in reduced inflammation and, in particular, reduced expression of TNF-α expression in mice, which in turn results in reduced hearing loss (). TLR4 knockout mice also show relatively more resistance to noise, and the absence of TLR4 suppresses the expression of MHC-II in macrophages and reduces the antigen presentation activity of macrophages. TLR4 dysfunction inhibits IL-6 production in the organ of Corti (Vethanayagam et al., 2016), while activation of NF-κB is concomitant with the morphological transformation of macrophages, which is further evidence that macrophages are activated via TLR4 (). Together, these studies demonstrate the negative effects that macrophages can have in the inner ear.
FIGURE 5
Inflammatory Cytokines Participate in Cochlear Injury
Inflammatory factors are produced at different levels at the different time points, and they are distributed in different anatomical sites. The expression of gene encoding TNF-α is upregulated at 6 h after noise-induced damage, and IL-1β and IL-6 expression increases as early as 3 h after noise damage, while IL-6 expression decreases at 24 h, indicating transient upregulation in the cochlea in response to noise exposure (; Wakabayashi et al., 2010; Tan et al., 2016; ). Cisplatin injection results in an increase in TNF-α, IL-1β, and IL-6, and TNF-α and IL-1β expression is observed throughout the organ of Corti, the spiral ligament, and the stria vascularis in the cochlea. TNF-α inhibitors can not only completely inhibit TNF-α expression but also significantly block IL-1β and IL-6 expression. These observations imply that TNF-α plays a dominant and central role in the pathophysiology of HC damage induced by cisplatin ().
IL-1β expression is a general cochlear response to trauma (), and a lack of CX3CR1 can result in enhanced expression of IL-1β in the spiral ganglion after ototoxic or acoustic injury (). IL-6 and its receptor are present in the stria vascularis, spiral ligament, and spiral ganglion, and IL-6 receptor is also detected in HCs after noise exposure (; Wakabayashi et al., 2010). IL-6 is initially expressed in the cytoplasm of Type III and Type IV fibrocytes, and it expands to a broader area throughout the lateral wall, eventually reaching the stria vascularis. Because the macrophage marker Iba-1 staining is not expressed in the IL-6 expression region, the early IL-6 expression might not be due to macrophage activation (). HLN exposure induces markedly higher expression of TNF-α, IL-1β, and IL-6 as compared with LLN exposure, which suggest that more severe local inflammation is induced in the HLN group ().
ICAM-1 is an adhesion molecule that mediates leukocyte migration to vascular endothelial cells during inflammation, and ICAM-1 is expressed on fibrocytes in the inferior part of the spiral ligament and in vascular endothelial cells under physiological conditions (; Tornabene et al., 2006). After HLN exposure, the gene expression of ICAM-1 in the spiral ligament and endosteal cells is upregulated at 6 h, and the protein expression begins at 24 h, subsequently reaching a maximum at around 2–4 days and then returning to basal levels by 14 days (Tornabene et al., 2006; Tan et al., 2016). LLN can also enhance ICAM-1 expression in macrophages of the basilar membrane ().
Regulation of Macrophage Migration or Function to Improve Hearing
Inhibition of Macrophage Migration After Cochlear Injury
Inhibition of macrophage migration after cochlear injury prevents hearing loss, HC loss, and damage to SGNs. Macrophages and monocytes can be depleted by clodronate liposomes, and after noise exposure, mice treated with clodronate have decreased macrophage recruitment into the stria vascularis and exhibit significantly reduced hearing threshold shifts and less outer HC loss in the lower-apical cochlear turn (). Macrophage migration inhibitory factor (MIF) plays a role in neural development and is detected in the stria vascularis and spiral ligament. Lack of MIF results in significant loss of outer HCs and reduced numbers of SGCs and thus results in profound hearing loss after noise exposure (). Inducible nitric oxide synthase (iNOS) from PVM/Ms can recruit BMDCs to the cochlear BLB after acoustic injury, and stromal cell-derived factor-1alpha (SDF-1α) and its chemokine receptor 4 (CXCR4) are required for the BMDC recruitment triggered by iNOS. Inhibiting iNOS/SDF-1α signaling reduces the BMDC infiltration required for cochlear vascular repair as evidenced by decreased vascular density (). These findings imply that inhibition of macrophage migration might be a promising therapeutic option for preventing hearing loss after cochlear injury.
Inhibiting Inflammatory Cytokine Expression by Macrophages or Blocking the Activity of Inflammatory Cytokines
Inhibiting the expression of certain inflammatory cytokines might be an important means of protecting the inner ear after injury. Neomycin can activate macrophages in the basilar membrane in vivo or in vitro (), and minocycline can inhibit the release of inflammatory cytokines by macrophages (; ; ). Inhibiting the activation of macrophages with minocycline can reduce the HC loss caused by neomycin and can improve hearing function in neomycin-treated mice ().
Heat shock transcription factor 1 (HSF1) mainly plays a role in regulating heat shock response, but it also directly or indirectly inhibits inflammatory cytokine expression. IL-1β and IL-6 expression and elevated auditory thresholds after noise exposure are significantly suppressed after administration of geranylacetone, which activates HSF1 (). Acetyl-L-carnitine prevents the increased levels of TNF-α, IL-1β, and IL-6 induced by cisplatin and thus shows protective effects against cisplatin-induced ototoxicity (). MR16-1 is an anti-IL-6 receptor neutralizing antibody that can suppress the effect of IL-6. After noise injury, blocking IL-6 signaling with MR16-1 significantly reduces the activation of cochlear macrophages in the spiral ganglion and reduces loss of SGNs, but does not lead to changes in the organ of Corti. Also, inhibiting IL-6 signaling improves low-frequency ABR thresholds in response to HLN exposure (Wakabayashi et al., 2010). Thus, MR16-1 has a protective effect in the noise-damaged cochlea.
Etanercept, a TNF-α inhibitor, significantly improves cochlear microcirculation, reduces the number of cells infiltrating into the cochlea and cochlear fibrosis, and protects against hearing loss after cochlear injury (; Wang et al., 2003; ; ). Anti-ICAM-1antibodies (anti-ICAM-1Ab) may have preventive effects on cochlear damage as assessed by changes in auditory threshold and cochlear blood flow (). However, deficiency in IL-1β does not show any significant reduction in threshold shifts at any examined frequency, nor does it have any effect on macrophages entering the cochlea ().
Mesenchymal Stem Cells Regulate the Differentiation of Macrophages Into M1 and M2 Types
In recent years, stem cell application has emerged as a promising treatment modality for various auditory disorders. Preclinical animal studies have shown that mesenchymal stem cells (MSCs) can be used to treat SNHL (; ) because they have neuroprotective, anti-apoptotic, and anti-inflammatory properties. MSCs can interact with a variety of immune cells including T cells and macrophages, and they exert immunosuppressive properties (Zhou et al., 2011), which indicates that MSCs might be a novel therapeutic method for treating inner ear disorders such as HC damage caused by inflammation.
Human umbilical cord (UC) and BM MSCs have been used in the treatment of SNHL (; ). MSCs can be found in the stria vascularis, the perilymphatic space, the organ of Corti, the basilar membrane, the spiral ganglion, and around the cochlear nerve fibers after transplantation (; ), and verified that it is safe to transplant autologous BM MSCs into SNHL patients. The administration of MSCs does not lead to the generation of any oxidative stress, the production of proinflammatory cytokines, or the activation of apoptosis (), and thus the MSCs have no significant side effects on hearing thresholds ().
Recent studies have also demonstrated that MSC-based therapy has a remarkable effect on neurodegenerative diseases (; ; ; ), which is in large part due to the immunomodulatory effects mediated by the interaction between MSCs and macrophages (Uccelli et al., 2008). It is challenging to distinguish between M1 and M2 macrophages (especially in vivo), because the two states are plastic. A series of studies have suggested that MSCs are able to regulate the differentiation of macrophages to the M2 type (; ; ), and considerable evidence suggests that the activation and maturation of innate immune cells can be inhibited by MSC-derived soluble factors, such as PGE2 and TSG-6, which can cause monocytes or M1 macrophages to convert into IL-10-expressing M2 populations (; ). Preclinical studies have shown promising results in the application of MSCs for the treatment of pulmonary disorders, with MSCs promoting M2 macrophages (). In a rat model of type 2 diabetes, intravenous administration of UC-MSCs reduced insulin resistance by promoting the M2 phenotype (Xie et al., 2016), and MSCs are also capable of converting microglia from a detrimental pro-inflammatory phenotype to a neuroprotective anti-inflammatory phenotype in the CNS by activating CX3CL1/CX3CR1 signaling (). Taken together, these results suggest that MSCs can suppress inflammatory macrophages, which makes the transplantation of MSCs very promising for treating SNHL.
Concluding Remarks
Tissue-resident macrophages are widely distributed in different anatomical sites of the cochlea. When the cochlea suffers from injury, monocytes in the circulatory system migrate into the cochlea and transform into mature macrophages, which combine with tissue-resident macrophages to participate in immune responses. After acoustic and ototoxic injury, or in aged cochleae, cochlear HC loss is regarded as the initial damage. HC injury alone is sufficient to attract macrophages into the sensory epithelium and spiral ganglion (). The CX3CL1/CX3CR1 and CCL2/CCR2 signaling pathways have been shown to play a major role in recruiting macrophages into the cochlea. However, these two chemokines are still not enough to explain the detrimental and beneficial effect of the macrophage on auditory structure when CX3CR1 and CCR2 are knocked out. Current evidence suggests that macrophages also play a role in regenerating HCs in addition to damaging HCs after activation. At the same time, they also have the function of protecting SGNs and ribbon synapses after injury. The question, then, is why do macrophages have different effects on different structures of the cochlea? Studies have shown that tissue macrophages play an important role in early and acute injury, while recruited macrophages have an essential function in late and chronic injury. The differences in phenotype and activity between newly recruited macrophages and resident macrophages are still unclear. Future studies should explore the recruitment signaling pathways in more detail, determine the specific functions of cochlear macrophages under physiological conditions, and distinguish between resident macrophages and infiltrated macrophages. Even more importantly, it would be of great interest to clarify how macrophages perform their different functions when they enter different structures of the cochlea. Identifying the recruitment signaling pathways and cochlear macrophage functions will be a pivotal step to revealing new targets for the prevention and treatment of cochlear injury.
Damaged cochlear cells release DAMPs, which can activate PRR on the surface of macrophages. The PRR activation results in the production of inflammatory cytokines through the activation of a series of downstream signaling pathways. At present, the production of inflammation has been extensively studied, while the resolution of inflammation still needs to be further explored. Inhibiting inflammatory responses or promoting the transformation of macrophages to the M2 phenotype is necessary for tissue repair after stress. In future studies, deeper understanding of the biological process of macrophages and exploring the method of regulating the migration and function of macrophages will benefit patients suffering from SNHL.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Funding
This work was supported by grants from the National Key R&D Program of China (Nos. 2017YFA0103903 and 2019YFA0111400), the Strategic Priority Research Program of the Chinese Academy of Science (XDA16010303), the National Natural Science Foundation of China (Nos. 82030029, 81970882, 81670938, and 82071056), the Natural Science Foundation from Jiangsu Province (BE2019711 and BK20161116), the Shenzhen Fundamental Research Program (JCYJ20190814093401920), and the Nanjing Medical Science and Technique Development Foundation (No. QRX17033).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AltunZ.OlgunY.ErcetinP.AktasS.KirkimG.SerbetciogluB.et al (2014). Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.Cell Prolif.4772–80. 10.1111/cpr.12080
2
ArpornchayanonW.CanisM.IhlerF.SettevendemieC.StriethS. (2013). TNF-alpha inhibition using etanercept prevents noise-induced hearing loss by improvement of cochlear blood flow in vivo.Int. J. Audiol.52545–552. 10.3109/14992027.2013.790564
3
BainC. C.Bravo-BlasA.ScottC. L.PerdigueroE. G.GeissmannF.HenriS.et al (2014). Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice.Nat. Immunol.15929–937. 10.1038/ni.2967
4
BasE.GoncalvesS.AdamsM.DinhC. T.BasJ. M.Van De WaterT. R.et al (2015). Spiral ganglion cells and macrophages initiate neuro-inflammation and scarring following cochlear implantation.Front. Cell Neurosci.9:303. 10.3389/fncel.2015.00303
5
BhaveS. A.OesterleE. C.ColtreraM. D. (1998). Macrophage and microglia-like cells in the avian inner ear.J. Comp. Neurol.398241–256. 10.1002/(sici)1096-9861(19980824)398:2<241::aid-cne6>3.0.co;2-0
6
BrazaF.DirouS.ForestV.SauzeauV.HassounD.ChesneJ.et al (2016). Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma.Stem Cells.341836–1845. 10.1002/stem.2344
7
BrownL. N.XingY.NobleK. V.BarthJ. L.PanganibanC. H.SmytheN. M.et al (2017). Macrophage-mediated glial cell elimination in the postnatal mouse cochlea.Front. Mol. Neurosci.10:407. 10.3389/fnmol.2017.00407
8
CarrilloS. A.Anguita-SalinasC.PenaO. A.MoralesR. A.Munoz-SanchezS.Munoz-MontecinosC.et al (2016). Macrophage recruitment contributes to regeneration of mechanosensory hair cells in the zebrafish lateral line.J. Cell Biochem.1171880–1889. 10.1002/jcb.25487
9
ChiossoneL.ConteR.SpaggiariG. M.SerraM.RomeiC.BelloraF.et al (2016). Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses.Stem Cells.341909–1921. 10.1002/stem.2369
10
ChorathK. T.WillisM. J.Morton-GonzabaN.HumannW. J.MoreiraA. (2019). Mesenchymal stem cells for sensorineural hearing loss: protocol for a systematic review of preclinical studies.Syst. Rev.8:126. 10.1186/s13643-019-1015-7
11
DaiM.YangY.OmelchenkoI.NuttallA. L.KachelmeierA.XiuR.et al (2010). Bone marrow cell recruitment mediated by inducible nitric oxide synthase/stromal cell-derived factor-1alpha signaling repairs the acoustically damaged cochlear blood-labyrinth barrier.Am. J. Pathol.1773089–3099. 10.2353/ajpath.2010.100340
12
DhukhwaA.BhattaP.ShethS.KorrapatiK.TieuC.MamillapalliC.et al (2019). Targeting inflammatory processes mediated by TRPVI and TNF-alpha for treating noise-induced hearing loss.Front. Cell Neurosci.13:444. 10.3389/fncel.2019.00444
13
DongY.ZhangC.FryeM.YangW.DingD.SharmaA.et al (2018). Differential fates of tissue macrophages in the cochlea during postnatal development.Hear. Res.365110–126. 10.1016/j.heares.2018.05.010
14
DuX.ChoiC. H.ChenK.ChengW.FloydR. A.KopkeR. D. (2011). Reduced formation of oxidative stress biomarkers and migration of mononuclear phagocytes in the cochleae of chinchilla after antioxidant treatment in acute acoustic trauma.Int. J. Otolaryngol.2011:612690. 10.1155/2011/612690
15
EchtelerS. M.MagardinoT.RontalM. (2005). Spatiotemporal patterns of neuronal programmed cell death during postnatal development of the gerbil cochlea.Dev. Brain Res.157192–200. 10.1016/j.devbrainres.2005.04.004
16
EshraghiA. A.OcakE.ZhuA.MittalJ.DaviesC.ShahalD.et al (2020). Biocompatibility of bone marrow-derived mesenchymal stem cells in the rat inner ear following trans-tympanic administration.J. Clin. Med.9:1711. 10.3390/jcm9061711
17
FanJ.LiY.LevyR. M.FanJ. J.HackamD. J.VodovotzY.et al (2007). Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling.J. Immunol.1786573–6580. 10.4049/jimmunol.178.10.6573
18
FredeliusL.Rask-AndersenH. (1990). The role of macrophages in the disposal of degeneration products within the organ of corti after acoustic overstimulation.Acta Otolaryngol.10976–82. 10.3109/00016489009107417
19
FryeM. D.RyanA. F.KurabiA. (2019). Inflammation associated with noise-induced hearing loss.J. Acoust. Soc. Am.146:4020. 10.1121/1.5132545
20
FryeM. D.YangW.ZhangC.XiongB.HuB. H. (2017). Dynamic activation of basilar membrane macrophages in response to chronic sensory cell degeneration in aging mouse cochleae.Hear. Res.344125–134. 10.1016/j.heares.2016.11.003
21
FryeM. D.ZhangC.HuB. H. (2018). Lower level noise exposure that produces only TTS modulates the immune homeostasis of cochlear macrophages.J. Neuroimmunol.323152–166. 10.1016/j.jneuroim.2018.06.019
22
FujiokaM.KanzakiS.OkanoH. J.MasudaM.OgawaK.OkanoH. (2006). Proinflammatory cytokines expression in noise-induced damaged cochlea.J. Neurosci. Res.83575–583. 10.1002/jnr.20764
23
FujiokaM.OkamotoY.ShindenS.OkanoH. J.OkanoH.OgawaK.et al (2014). Pharmacological inhibition of cochlear mitochondrial respiratory chain induces secondary inflammation in the lateral wall: a potential therapeutic target for sensorineural hearing loss.PLoS One9:e90089. 10.1371/journal.pone.0090089
24
GeissmannF.JungS.LittmanD. R. (2003). Blood monocytes consist of two principal subsets with distinct migratory properties.Immunity1971–82. 10.1016/s1074-7613(03)00174-2
25
GinhouxF.GuilliamsM. (2016). Tissue-resident macrophage ontogeny and homeostasis.Immunity44439–449. 10.1016/j.immuni.2016.02.024
26
GiuntiD.ParodiB.UsaiC.VerganiL.CasazzaS.BruzzoneS.et al (2012). Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1.Stem Cells302044–2053. 10.1002/stem.1174
27
Glavaski-JoksimovicA.BohnM. C. (2013). Mesenchymal stem cells and neuroregeneration in Parkinson’s disease.Exp. Neurol.24725–38. 10.1016/j.expneurol.2013.03.016
28
GuW.SongL.LiX. M.WangD.GuoX. J.XuW. G. (2015). Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways.Sci. Rep.5:8733. 10.1038/srep08733
29
HajivaliliM.PourgholiF.KafilH. S.Jadidi-NiaraghF.YousefiM. (2016). Mesenchymal stem cells in the treatment of amyotrophic lateral sclerosis.Curr. Stem Cell Res. Ther.1141–50. 10.2174/1574888x10666150902095031
30
HerranenA.IkaheimoK.VirkkalaJ.PirvolaU. (2018). The stress response in the non-sensory cells of the cochlea under pathological conditions-possible role in mediating noise vulnerability.J. Assoc. Res. Otolaryngol.19637–652. 10.1007/s10162-018-00691-2
31
HiroseK.DiscoloC. M.KeaslerJ. R.RansohoffR. (2005). Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma.J. Comp. Neurol.489180–194. 10.1002/cne.20619
32
HiroseK.LiS. Z. (2019). The role of monocytes and macrophages in the dynamic permeability of the blood-perilymph barrier.Hear. Res.37449–57. 10.1016/j.heares.2019.01.006
33
HiroseK.LiS. Z.OhlemillerK. K.RansohoffR. M. (2014). Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.J. Assoc. Res. Otolaryngol.15555–570. 10.1007/s10162-014-0458-8
34
HiroseK.LibermanM. C. (2003). Lateral wall histopathology and endocochlear potential in the noise-damaged mouse cochlea.J. Assoc. Res. Otolaryngol.4339–352. 10.1007/s10162-002-3036-4
35
HiroseK.RutherfordM. A.WarcholM. E. (2017). Two cell populations participate in clearance of damaged hair cells from the sensory epithelia of the inner ear.Hear. Res.35270–81. 10.1016/j.heares.2017.04.006
36
HuB. H.ZhangC.FryeM. D. (2018). Immune cells and non-immune cells with immune function in mammalian cochleae.Hear. Res.36214–24. 10.1016/j.heares.2017.12.009
37
HuangL. C.BarclayM.LeeK.PeterS.HousleyG. D.ThorneP. R.et al (2012). Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea.Neural. Dev.7:38. 10.1186/1749-8104-7-38
38
HumeD. A.UnderhillD. M.SweetM. J.OzinskyA. O.LiewF. Y.AderemA. (2001). Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.BMC Immunol.2:11. 10.1186/1471-2172-2-11
39
IwaiH.BabaS.OmaeM.LeeS.YamashitaT.IkeharaS. (2008). Maintenance of systemic immune functions prevents accelerated presbycusis.Brain Res.12088–16. 10.1016/j.brainres.2008.02.069
40
IwaiH.LeeS.InabaM.SugiuraK.BabaS.TomodaK.et al (2003). Correlation between accelerated presbycusis and decreased immune functions.Exp. Gerontol.38319–325. 10.1016/s0531-5565(02)00177-8
41
JabbaS. V.OelkeA.SinghR.MagantiR. J.FlemingS.WallS. M.et al (2006). Macrophage invasion contributes to degeneration of stria vascularis in Pendred syndrome mouse model.BMC Med.4:37. 10.1186/1741-7015-4-37
42
JangS.ChoH. H.KimS. H.LeeK. H.JunJ. Y.ParkJ. S.et al (2015). Neural-induced human mesenchymal stem cells promote cochlear cell regeneration in deaf Guinea pigs.Clin. Exp. Otorhinolaryngol.883–91. 10.3342/ceo.2015.8.2.83
43
JiangY.ZhangJ.RaoY.ChenJ.ChenK.TangY. (2019). Lipopolysaccharide disrupts the cochlear blood-labyrinth barrier by activating perivascular resident macrophages and up-regulating MMP-9.Int. J. Pediatr. Otorhinolaryngol.127:109656. 10.1016/j.ijporl.2019.109656
44
JungS.AlibertiJ.GraemmelP.SunshineM. J.KreutzbergG. W.SherA.et al (2000). Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.Mol. Cell Biol.204106–4114. 10.1128/mcb.20.11.4106-4114.2000
45
KariyaS.OkanoM.MaedaY.HiraiH.HigakiT.NoyamaY.et al (2015). Macrophage migration inhibitory factor deficiency causes prolonged hearing loss after acoustic overstimulation.Otol. Neurotol.361103–1108. 10.1097/MAO.0000000000000755
46
KarussisD.KarageorgiouC.Vaknin-DembinskyA.Gowda-KurkalliB.GomoriJ. M.KassisI.et al (2010). Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.Arch. Neurol.671187–1194. 10.1001/archneurol.2010.248
47
KaurT.ClaymanA. C.NashA. J.SchraderA. D.WarcholM. E.OhlemillerK. K. (2019). Lack of fractalkine receptor on macrophages impairs spontaneous recovery of ribbon synapses after moderate noise trauma in C57BL/6 mice.Front. Neurosci.13:620. 10.3389/fnins.2019.00620
48
KaurT.OhlemillerK. K.WarcholM. E. (2018). Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.J. Comp. Neurol.526824–835. 10.1002/cne.24369
49
KaurT.ZamaniD.TongL.RubelE. W.OhlemillerK. K.HiroseK.et al (2015). Fractalkine signaling regulates macrophage recruitment into the cochlea and promotes the survival of spiral ganglion neurons after selective hair cell lesion.J. Neurosci.3515050–15061. 10.1523/JNEUROSCI.2325-15.2015
50
KishimotoI.OkanoT.NishimuraK.MotohashiT.OmoriK. (2019). Early development of resident macrophages in the mouse cochlea depends on yolk sac hematopoiesis.Front. Neurol.10:1115. 10.3389/fneur.2019.01115
51
KoJ. H.LeeH. J.JeongH. J.KimM. K.WeeW. R.YoonS. O.et al (2016). Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye.Proc. Natl. Acad. Sci. U.S.A.113158–163. 10.1073/pnas.1522905113
52
LadrechS.WangJ.SimonneauL.PuelJ. L.LenoirM. (2007). Macrophage contribution to the response of the rat organ of Corti to amikacin.J. Neurosci. Res.851970–1979. 10.1002/jnr.21335
53
LangH.JyothiV.SmytheN. M.DubnoJ. R.SchulteB. A.SchmiedtR. A. (2010). Chronic reduction of endocochlear potential reduces auditory nerve activity: further confirmation of an animal model of metabolic presbyacusis.J. Assoc. Res. Otolaryngol.11419–434. 10.1007/s10162-010-0214-7
54
LangH.NishimotoE.XingY.BrownL. N.NobleK. V.BarthJ. L.et al (2016). Contributions of mouse and human hematopoietic cells to remodeling of the adult auditory nerve after neuron loss.Mol. Ther.242000–2011. 10.1038/mt.2016.174
55
LangH.SchulteB. A.SchmiedtR. A. (2005). Ouabain induces apoptotic cell death in type I spiral ganglion neurons, but not type II neurons.J. Assoc. Res. Otolaryngol.663–74. 10.1007/s10162-004-5021-6
56
LeeH. S.KimW. J.GongJ. S.ParkK. H. (2018). Clinical safety and efficacy of autologous bone marrow-derived mesenchymal stem cell transplantation in sensorineural hearing loss patients.J. Audiol. Otol.22105–109. 10.7874/jao.2017.00150
57
LeeJ. K.JinH. K.BaeJ. S. (2009). Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer’s disease mouse model.Neurosci. Lett.450136–141. 10.1016/j.neulet.2008.11.059
58
LimD. J. (1970). Surface ultrastructure of the cochlear perilymphatic space.J. Laryngol. Otol.84413–428. 10.1017/s0022215100072029
59
LimatolaC.RansohoffR. M. (2014). Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.Front. Cell Neurosci.8:229. 10.3389/fncel.2014.00229
60
LiuJ. T.ChenY. L.ChenW. C.ChenH. Y.LinY. W.WangS. H.et al (2012). Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization.J. Biomed. Biotechnol.2012:871272. 10.1155/2012/871272
61
LuB.RutledgeB. J.GuL.FiorilloJ.LukacsN. W.KunkelS. L.et al (1998). Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice.J. Exp. Med.187601–608. 10.1084/jem.187.4.601
62
Luz-CrawfordP.DjouadF.ToupetK.BonyC.FranquesaM.HoogduijnM. J.et al (2016). Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation.Stem Cells.34483–492. 10.1002/stem.2254
63
MaY.GuoW.YiH.RenL.ZhaoL.ZhangY.et al (2016). Transplantation of human umbilical cord mesenchymal stem cells in cochlea to repair sensorineural hearing.Am. J. Transl. Res.85235–5245.
64
MillsC. D.LeyK. (2014). M1 and M2 macrophages: the chicken and the egg of immunity.J. Innate. Immun.6716–726. 10.1159/000364945
65
MittalR.OcakE.ZhuA.PerdomoM. M.PenaS. A.MittalJ.et al (2020). Effect of bone marrow-derived mesenchymal stem cells on cochlear function in an experimental rat model.Anat. Rec. (Hoboken).303487–493. 10.1002/ar.24065
66
MizushimaY.FujimotoC.KashioA.KondoK.YamasobaT. (2017). Macrophage recruitment, but not interleukin 1 beta activation, enhances noise-induced hearing damage.Biochem. Biophys. Res. Commun.493894–900. 10.1016/j.bbrc.2017.09.124
67
NakamotoT.MikuriyaT.SugaharaK.HiroseY.HashimotoT.ShimogoriH.et al (2012). Geranylgeranylacetone suppresses noise-induced expression of proinflammatory cytokines in the cochlea.Auris Nasus Larynx39270–274. 10.1016/j.anl.2011.06.001
68
NemzouN. R.BulankinaA. V.KhimichD.GieseA.MoserT. (2006). Synaptic organization in cochlear inner hair cells deficient for the CaV1.3 (alpha1D) subunit of L-type Ca2+ channels.Neuroscience1411849–1860. 10.1016/j.neuroscience.2006.05.057
69
NengL.ZhangF.KachelmeierA.ShiX. (2013). Endothelial cell, pericyte, and perivascular resident macrophage-type melanocyte interactions regulate cochlear intrastrial fluid-blood barrier permeability.J. Assoc. Res. Otolaryngol.14175–185. 10.1007/s10162-012-0365-9
70
NengL.ZhangJ.YangJ.ZhangF.LopezI. A.DongM.et al (2015). Structural changes in thestrial blood-labyrinth barrier of aged C57BL/6 mice.Cell Tissue Res.361685–696. 10.1007/s00441-015-2147-2
71
OhG. S.KimH. J.ChoiJ. H.ShenA.KimC. H.KimS. J.et al (2011). Activation of lipopolysaccharide-TLR4 signaling accelerates the ototoxic potential of cisplatin in mice.J. Immunol.1861140–1150. 10.4049/jimmunol.1002183
72
OkanoT.NakagawaT.KitaT.KadaS.YoshimotoM.NakahataT.et al (2008). Bone marrow-derived cells expressing Iba1 are constitutively present as resident tissue macrophages in the mouse cochlea.J. Neurosci. Res.861758–1767. 10.1002/jnr.21625
73
OkayasuT.QuesnelA. M.O’MalleyJ. T.KamakuraT.NadolJ. B.Jr. (2020). The distribution and prevalence of macrophages in the cochlea following cochlear implantation in the human: an immunohistochemical study using anti-Iba1 antibody.Otol. Neurotol.41e304–e316. 10.1097/MAO.0000000000002495
74
O’MalleyJ. T.NadolJ. B.Jr.McKennaM. J. (2016). Anti CD163+, Iba1+, and CD68+ cells in the adult human inner ear: normal distribution of an unappreciated class of macrophages/microglia and implications for inflammatory otopathology in humans.Otol. Neurotol.3799–108. 10.1097/MAO.0000000000000879
75
OwolabiS. A.SaabC. Y. (2006). Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn.FEBS Lett.5804306–4310. 10.1016/j.febslet.2006.06.087
76
ParkH. S.JungH. Y.ParkE. Y.KimJ.LeeW. J.BaeY. S. (2004). Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B.J. Immunol.1733589–3593. 10.4049/jimmunol.173.6.3589
77
SatoE.ShickH. E.RansohoffR. M.HiroseK. (2008). Repopulation of cochlear macrophages in murine hematopoietic progenitor cell chimeras: the role of CX3CR1.J. Comp. Neurol.506930–942. 10.1002/cne.21583
78
SatoE.ShickH. E.RansohoffR. M.HiroseK. (2010). Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury.J. Assoc. Res. Otolaryngol.11223–234. 10.1007/s10162-009-0198-3
79
SatohH.FiresteinG. S.BillingsP. B.HarrisJ. P.KeithleyE. M. (2002). Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation.Laryngoscope1121627–1634. 10.1097/00005537-200209000-00019
80
SautterN. B.ShickE. H.RansohoffR. M.CharoI. F.HiroseK. (2006). CC chemokine receptor 2 is protective against noise-induced hair cell death: studies in CX3CR1(+/GFP) mice.J. Assoc. Res. Otolaryngol.7361–372. 10.1007/s10162-006-0051-x
81
SchaeferL. (2014). Complexity of danger: the diverse nature of damage-associated molecular patterns.J. Biol. Chem.28935237–35245. 10.1074/jbc.R114.619304
82
SchaferD. P.StevensB. (2015). Microglia function in central nervous system development and plasticity.Cold Spring Harb. Perspect. Biol.7:a020545. 10.1101/cshperspect.a020545
83
SchmiedtR. A.OkamuraH. O.LangH.SchulteB. A. (2002). Ouabain application to the round window of the gerbil cochlea: a model of auditory neuropathy and apoptosis.J. Assoc. Res. Otolaryngol.3223–233. 10.1007/s1016200220017
84
SeidmanM. D.TangW.ShirwanyN.BaiU.RubinC. J.HenigJ. P.et al (2009). Anti-intercellular adhesion molecule-1 antibody’s effect on noise damage.Laryngoscope119707–712. 10.1002/lary.20109
85
SerbinaN. V.PamerE. G. (2006). Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.Nat. Immunol.7311–317. 10.1038/ni1309
86
ShanS.Hong-MinT.YiF.Jun-PengG.YueF.Yan-HongT.et al (2011). New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson’s disease.Neurobiol. Aging32443–458. 10.1016/j.neurobiolaging.2009.03.004
87
ShiX. (2009). Cochlear pericyte responses to acoustic trauma and the involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor.Am. J. Pathol.1741692–1704. 10.2353/ajpath.2009.080739
88
ShiX. (2010). Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells.Cell Tissue Res.34221–30. 10.1007/s00441-010-1040-2
89
ShinS. A.LyuA. R.JeongS. H.KimT. H.ParkM. J.ParkY. H. (2019). Acoustic trauma modulates cochlear blood flow and vasoactive factors in a rodent model of noise-induced hearing loss.Int. J. Mol. Sci.20:5316. 10.3390/ijms20215316
90
SoH.KimH.LeeJ. H.ParkC.KimY.KimE.et al (2007). Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.J. Assoc. Res. Otolaryngol.8338–355. 10.1007/s10162-007-0084-9
91
SunS.CaoH.HanM.LiT. T.PanH. L.ZhaoZ. Q.et al (2007). New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis.Pain12964–75. 10.1016/j.pain.2006.09.035
92
SunS.YuH.YuH.HonglinM.NiW.ZhangY.et al (2015). Inhibition of the activation and recruitment of microglia-like cells protects against neomycin-induced ototoxicity.Mol. Neurobiol.51252–267. 10.1007/s12035-014-8712-y
93
SuzukiM.HarrisJ. P. (1995). Expression of intercellular adhesion molecule-1 during inner ear inflammation.Ann. Otol. Rhinol. Laryngol.10469–75. 10.1177/000348949510400111
94
TanW. J.ThorneP. R.VlajkovicS. M. (2016). Characterisation of cochlear inflammation in mice following acute and chronic noise exposure.Histochem. Cell Biol.146219–230. 10.1007/s00418-016-1436-5
95
TangD.KangR.CoyneC. B.ZehH. J.LotzeM. T. (2012). PAMPs and DAMPs: signal 0s that spur autophagy and immunity.Immunol. Rev.249158–175. 10.1111/j.1600-065X.2012.01146.x
96
TornabeneS. V.SatoK.PhamL.BillingsP.KeithleyE. M. (2006). Immune cell recruitment following acoustic trauma.Hear. Res.222115–124. 10.1016/j.heares.2006.09.004
97
TsungA.KluneJ. R.ZhangX.JeyabalanG.CaoZ.PengX.et al (2007). HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.J. Exp. Med.2042913–2923. 10.1084/jem.20070247
98
UccelliA.MorettaL.PistoiaV. (2008). Mesenchymal stem cells in health and disease.Nat. Rev. Immunol.8726–736. 10.1038/nri2395
99
VethanayagamR. R.YangW.DongY.HuB. H. (2016). Toll-like receptor 4 modulates the cochlear immune response to acoustic injury.Cell Death Dis.7:e2245. 10.1038/cddis.2016.156
100
WakabayashiK.FujiokaM.KanzakiS.OkanoH. J.ShibataS.YamashitaD.et al (2010). Blockade of interleukin-6 signaling suppressed cochlear inflammatory response and improved hearing impairment in noise-damaged mice cochlea.Neurosci. Res.66345–352. 10.1016/j.neures.2009.12.008
101
WakeH.MoorhouseA. J.JinnoS.KohsakaS.NabekuraJ. (2009). Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals.J. Neurosci.293974–3980. 10.1523/JNEUROSCI.4363-08.2009
102
WangX.TruongT.BillingsP. B.HarrisJ. P.KeithleyE. M. (2003). Blockage of immune-mediated inner ear damage by etanercept.Otol. Neurotol.2452–57. 10.1097/00129492-200301000-00012
103
WangY.HiroseK.LibermanM. C. (2002). Dynamics of noise-induced cellular injury and repair in the mouse cochlea.J. Assoc. Res. Otolaryngol.3248–268. 10.1007/s101620020028
104
WangZ.LiH. (2000). Microglia-like cells in rat organ of Corti following aminoglycoside ototoxicity.Neuroreport111389–1393. 10.1097/00001756-200005150-00008
105
WarcholM. E. (1997). Macrophage activity in organ cultures of the avian cochlea: demonstration of a resident population and recruitment to sites of hair cell lesions.J. Neurobiol.33724–734.
106
WarcholM. E.SchwendenerR. A.HiroseK. (2012). Depletion of resident macrophages does not alter sensory regeneration in the avian cochlea.PLoS One7:e51574. 10.1371/journal.pone.0051574
107
WuY.Dissing-OlesenL.MacVicarB. A.StevensB. (2015). Microglia: dynamic mediators of synapse development and plasticity.Trends Immunol.36605–613. 10.1016/j.it.2015.08.008
108
XieZ.HaoH.TongC.ChengY.LiuJ.PangY.et al (2016). Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.Stem Cells34627–639. 10.1002/stem.2238
109
YangS.CaiQ.VethanayagamR. R.WangJ.YangW.HuB. H. (2016). Immune defense is the primary function associated with the differentially expressed genes in the cochlea following acoustic trauma.Hear. Res.333283–294. 10.1016/j.heares.2015.10.010
110
YangW.VethanayagamR. R.DongY.CaiQ.HuB. H. (2015). Activation of the antigen presentation function of mononuclear phagocyte populations associated with the basilar membrane of the cochlea after acoustic overstimulation.Neuroscience3031–15. 10.1016/j.neuroscience.2015.05.081
111
YangY.DaiM.WilsonT. M.OmelchenkoI.KlimekJ. E.WilmarthP. A.et al (2011). Na+/K+-ATPase alpha1 identified as an abundant protein in the blood-labyrinth barrier that plays an essential role in the barrier integrity.PLoS One6:e16547. 10.1371/journal.pone.0016547
112
ZhangC.SunW.LiJ.XiongB.FryeM. D.DingD.et al (2017). Loss of sestrin 2 potentiates the early onset of age-related sensory cell degeneration in the cochlea.Neuroscience361179–191. 10.1016/j.neuroscience.2017.08.015
113
ZhangF.DaiM.NengL.ZhangJ. H.ZhiZ.FridbergerA.et al (2013). Perivascular macrophage-like melanocyte responsiveness to acoustic trauma–a salient feature of strial barrier associated hearing loss.FASEB J.273730–3740. 10.1096/fj.13-232892
114
ZhangG.ZhengH.PyykkoI.ZouJ. (2019). The TLR-4/NF-kappaB signaling pathway activation in cochlear inflammation of rats with noise-induced hearing loss.Hear. Res.37959–68. 10.1016/j.heares.2019.04.012
115
ZhangW.DaiM.FridbergerA.HassanA.DegagneJ.NengL.et al (2012). Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier.Proc. Natl. Acad. Sci. U.S.A.10910388–10393. 10.1073/pnas.1205210109
116
ZhouY.YuanJ.ZhouB.LeeA. J.LeeA. J.GhawjiM.Jr.et al (2011). The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice.Immunology133133–140. 10.1111/j.1365-2567.2011.03421.x
Summary
Keywords
macrophages, cochlear injury, auditory structure, sterile inflammation, immune responses
Citation
Zhang Y, Li Y, Fu X, Wang P, Wang Q, Meng W, Wang T, Yang J and Chai R (2021) The Detrimental and Beneficial Functions of Macrophages After Cochlear Injury. Front. Cell Dev. Biol. 9:631904. doi: 10.3389/fcell.2021.631904
Received
21 November 2020
Accepted
14 July 2021
Published
11 August 2021
Volume
9 - 2021
Edited by
Chen Zhang, Capital Medical University, China
Reviewed by
Richard Salvi, University at Buffalo, United States; Huib Versnel, University Medical Center Utrecht, Netherlands
Updates
Copyright
© 2021 Zhang, Li, Fu, Wang, Wang, Meng, Wang, Yang and Chai.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Meng, mengw@njtrh.orgTian Wang, tianwang@csu.edu.cnJianming Yang, Jmyang88@163.comRenjie Chai, renjiec@seu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.